Company Overview
Bangkok Lab and Cosmetic Public Company Limited (BLC)
was established on September 30, 1992 by a group of three pharmacists: Mr. Suvit Ngampoopun, Mr. Subhachai Saibour, and Mr. Somchai Phisphahutharn. Lying at the heart of the operation was the production of generic drugs in hopes to provide Thai people with greater access to quality medicines, and therefore establishing sustainable health stability.
Over the course of 30 years, BLC has grown to become a comprehensive healthcare solutions group, comprising generic and new generic drugs, herbal medicines, animal medicines, cosmetics, food supplements, and other health products. The Company’s operation covers the complete value chain of healthcare business, from research and development, manufacturing with international standards, sales and marketing, to distribution to partnering businesses and customers.
With its commitment to growing business based on knowledge and innovations, the Company set up BLC Research Center designed to drive innovations and technologies for the Company's product offerings with technology transfer from the research facilities of both government and business sectors.
For its manufacturing prowess, BLC has achieved multiple certifications for quality and management such as GMP PIC/S, ISO/IEC 17025, ISO 22000 GHP (Good Hygiene Practices), HACCP (Hazard Analysis and Critical Point System), and ISO 14001. This offers proof of the Company's quality products at the highest international standards, that the products are effective and safe for consumers as well as environmentally-friendly.
Beyond generic drugs and other health products, the Company places importance on organic herbs, raw materials that are readily available in Thailand and are packed with exceptional medicinal properties. Capitalizing on the Company’s knowhow in modern pharmaceutical technology, BLC has undertaken R&D to produce herbal extracts under the procedures that meet international standards and conducted studies to provide clinical evidence of efficacy of the products, making them an accepted alternative treatment alongside conventional treatments. These efforts help create health stability and economic growth in a sustainable manner.